➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
AstraZeneca
Boehringer Ingelheim
McKinsey
Mallinckrodt

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Litigation Details for PURDUE PHARMACEUTICAL PRODUCTS L.P. v. ACTAVIS ELIZABETH LLC (D.N.J. 2012)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in PURDUE PHARMACEUTICAL PRODUCTS L.P. v. ACTAVIS ELIZABETH LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for PURDUE PHARMACEUTICAL PRODUCTS L.P. v. ACTAVIS ELIZABETH LLC (D.N.J. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-08-23 1 Code, for infringement of U.S. Patent No. 7,682,628 (the “’628 Patent”). 7. This Court …Exhibit A. 16. FDA has listed U.S. Patent No. 7,682,628 in the Orange Book—formally known as Approved…PageID: 6 23. United States Patent No. 7,682,628, entitled “COMPOSITIONS FOR DELIVERING … the ’628 Patent. Count 1: Patent Infringement of the ’628 Patent … This is a civil action for patent infringement arising under the patent laws of the United States, External link to document
2014-04-09 152 18 PageID: 3312 about patents ‘with respect to which a claim of patent-infringement could reasonably…that either (1) no patent information has been filed with the FDA; (II) the patent …are four patents covering Intermezzo® which are listed in the Orange Book: (1) U.s. Patent No. 7,658,945…methods of use thereof; (2) U.S. Patent No. 7,682,628 (the “628 Patent”) entitled “Compositions for delivering… ds of use thereof (3) U.S. Patent No. 8,242,131 (the “131 Patent”) entitled “Methods of Treatin External link to document
2014-05-30 182 TWi's Counterclaims with Respect to U.S. Patent No. 7,682,628, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit… 23 August 2012 2:12-cv-05311 830 Patent Defendant District Court, D. External link to document
2014-06-11 185 ) United States Patent No. 7,658,945 (the “945 Patent”) which, like the ‘628 Patent, is entitled “Compositions… Patent”), 8,242,131 (the “131 Patent”), and 8,252,809 (the “809 Patent”). … There are four patents covering Intermezzo®: (1) the ‘628 Patent, entitled “Composition …‘131 Patent, entitled “Methods of treating middle-of-the-night insomnia;” (3) the ‘809 Patent, entitle… “It is a bedrock principle of patent law that the claims of a patent define the invention External link to document
2014-07-22 204 of TWI Pharmaceuticals, Inc. as to U.S. Patent Nos. 7,658,945, 7,682,628, and 8,252,809. Signed by Judge… 23 August 2012 2:12-cv-05311 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Merck
Medtronic
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.